Some women find that one medication causes more fatigue , bloating , or constipation than the other
Some participants favourably compared GLP-1 receptor agonists with other treatment options such as bypass surgery for obesity
Prospective patients who want to evaluate eligibility should use the official altRx page to review current pricing, eligibility criteria, telehealth informed consent, refund and cancellation terms, and the online evaluation process
Further testing is likely needed to exclude these as the cause of your symptoms
Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1
Thats what we like talking about off-air, so it bled in